Otsuka Pharma enters licensing agreement with 4D Molecular Therapeutics for ophthalmic gene therapy drug candidate, 4D-150: Tokyo Monday, November 3, 2025, 11:00 Hrs [IST] Otsuka ...
- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...
Tech Xplore on MSN
AI efficiency advances with spintronic memory chip that combines storage and processing
To make accurate predictions and reliably complete desired tasks, most artificial intelligence (AI) systems need to rapidly ...
Researchers have developed an optical computing system that performs feature extraction for quantitative trading with ...
INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...
Like other DNA medicines, INO-3107 has shown the ability to generate antigen-specific T cells that is not affected by anti-vector immunity impacting immunogenicity ... the FDA's accelerated approval ...
Today's businesses rely on effective end-to-end processes for consistently satisfying consumer and market needs. Achieving such corporate transitions successful ...
The tourism industry remains one of the most influential sectors in the world economy, supporting millions of jobs and generating trillions in revenue. Yet, behind its growth lies a web of suppliers, ...
Threat actors refine tactics with DNS attacks, new RATs, and Rust-based malware. Stay ahead with this week’s top ThreatsDay ...
The IDEX teams across the globe collectively delivered better than expected results in 2025. In our current phase three, ...
State Key Laboratory for Quality and Safety of Agro-Products, Key Laboratory of Biotechnology in Plant Protection of MARA, Zhejiang Key Laboratory of Green Plant Protection, Institute of Plant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback